Fam-trastuzumab deruxtecan-nxki (Enhertu®): A narrative drug review

Fam-trastuzumab deruxtecan-nxki (Enhertu®): A narrative drug review

Human epidermal growth factor receptor 2 (HER2) is a subset of the epidermal growth factor receptor family that expresses tyrosine kinase activity. Dimerization of the receptor initiates various cellular signaling pathways, ultimately leading to the proliferation and division of cancer cells. The HE...

Full description

Bibliographic Details
Main Authors: Ryan Varghese, Niraja Soman, Jainam Karsiya, Nimesh Bafna, Shona Nag
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
antibody-drug conjugate
anticancer drug
deruxtecan
human epidermal growth factor receptor 2
trastuzumab
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2022;volume=5;issue=4;spage=701;epage=709;aulast=Varghese

Similar Items

Similar Items